Abstract:Background: In recent years, tissue engineered bone by gene-modified stem cells compounded with scaffold materials in repair of bone defect has provided a novel thought for the bone tissue reconstruction. Objective: To explore the effect on repairing mandibular defect with human bone morphogenetic protein-2 (hBMP-2) gene transfected bone marrow mesenchymal stem cells (BMSCs) compounded with coral hydroxyapatite (CHA) scaffolds in osteoporotic rats. Design, time and setting: A randomized control animal experiment was completed at the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education from June 2005 to October 2006. Materials: Twenty-four unpregnant female Sprague-Dawley rats, 6 months old, SPF gradem weighing 250-300 g, were used to establish models of postmenopausal osteoporosis, The pcDNA3.1-hBMP-2 recombinant plasmid carrying hBMP-2 was offered by the Third Military Medical University of Chinese PLA; CHA scaffolds was offered by the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education. Methods: Twenty-four SD rats were divided into experimental group and control group at random, each containing 12 animals. Three months later, BMSCs harvested from osteoporotic rats were transfected by pcDNA3.1-hBMP-2 recombinant plasmid, and control group leaved untreated. Three days later, the transfected and untransfected autogenous BMSCs were seeded into CHA scaffolds, respectively. Then the cell/scaffolds composites were implanted into the critical-size defect area in the mandible bone of osteoporotic rats. Main outcome measures: At the 4th and 8th weeks after implantation, immunohistochemical analysis was performed to evaluate the new bone formation, and the amount of newly formed bone was detected semi-quantitatively at the 8th weeks. Results: All 24 SD rats were involved in the result analysis. 1 Newly formed bone was found at the margin of the defect area treated with the BMSCs modified by BMP-2 gene transfer at 4 weeks after implantation. The lamellar bone matrix was visible at 8 weeks. In the control group, only a little bone matrix was observed at the margin of CHA material at 4 weeks after implantation, however, the amount of newly formed bone was much less than the experimental group, and there was some adipose-like tissues at defect margins and central part at 8 weeks after implantation. 2 The percentage of newly formed bone area was (0.046±0.004)% and (0.233±0.015)% in the control group and the experimental group, respectively. There were significant differences in the amount of newly formed bone between two groups (P < 0.01). Conclusion: Tissue engineered bone formed by hBMP-2 gene-modified BMSCs in conjunction with CHA scaffolds, can allow large bone formation for treatment of mandibular defect in osteoporosis rats.

Transplantation of bone marrow mesenchymal stem cells and fibrin glue into extraction socket in maxilla promoted bone regeneration in osteoporosis rat

The Effect of Astragalus Extractive on Alveolar Bone Rebuilding Progress of Tooth Extracted Socket of Ovariectomied Rats.

In Vivo Alveolar Bone Regeneration by Bone Marrow Stem Cells/Fibrin Glue Composition

Bone marrow mesenchymal stem cells combined with endothelial progenitor cells for repair of alveolar bone defect in ovariectomized rats

Repairing mandibular defect by gene-modified bone marrow mesenchymal stem cells combined with coral hydroxyapatite scaffold in osteoporotic rats

Osteoprotegerin gene-modified BMSCs with hydroxyapatite scaffold for treating critical-sized mandibular defects in ovariectomized osteoporotic rats

In vitro cell behaviors of bone mesenchymal stem cells derived from normal and postmenopausal osteoporotic rats

Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Repair Critical-Sized Bone Defects through Enhanced Angiogenesis and Osteogenesis in Osteoporotic Rats

Periodontal Ligament Versus Bone Marrow Mesenchymal Stem Cells in Combination with Bio-Oss Scaffolds for Ectopic and in Situ Bone Formation: A Comparative Study in the Rat

Evaluation Of Bmmscs-Epcs Sheets For Repairing Alveolar Bone Defects In Ovariectomized Rats

A Study on Repairing Mandibular Defect by Means of Tissue-Engineering and Human Bone Morphogenetic Protein-2 Gene Transfection in Osteoporotic Rats

Promotion of Bone Formation in a Rat Osteoporotic Vertebral Body Defect Model via Suppression of Osteoclastogenesis by Ectopic Embryonic Calvaria Derived Mesenchymal Stem Cells

hBMP-7 Gene Modified Bone Marrow Stromal Cells on the Effects of Healing of Periodontal Furcation Defects in Osteoporosis Rats

Efficacy of Bone Marrow-Derived Stem Cells in Strengthening Osteoporotic Bone in a Rabbit Model

Amniotic fluid-derived stem cells mixed with platelet rich plasma for restoration of rat alveolar bone defect.

The Treatment Efficacy of Bone Tissue Engineering Strategy for Repairing Segmental Bone Defects under Osteoporotic Conditions

The Experimental Study of Periodontal Ligament Stem Cells Derived Exosomes with Hydrogel Accelerating Bone Regeneration on Alveolar Bone Defect

OPG gene-modified adipose-derived stem cells improve bone formation around implants in osteoporotic rat maxillae

Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats.

Sclerostin Transduced Bone Marrow Mesenchymal Stem Cells Promote Fracture Healing in Rats Through the Wnt/β-Catenin Signal Pathway

Transplantation of osteoporotic bone marrow stromal cells rejuvenated by the overexpression of SATB2 prevents alveolar bone loss in ovariectomized rats